Delta Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Hold
0
-$4 697
2023
Q4
Hold
0
-$2 680
2023
Q3
Hold
0
-$2 649
2023
Q2
Hold
0
-$6 654
2023
Q1
Hold
0
-$7 634
2022
Q4
Hold
0
667
2022
Q1
Hold
0
620
2021
Q4
Hold
0
651
2021
Q3
Hold
0
652
2021
Q2
Hold
0
625
2021
Q1
Hold
0
620
2020
Q4
Hold
0
607
2020
Q3
Hold
0
621
2020
Q2
Hold
0
639
2020
Q1
Hold
0
653
2019
Q4
Hold
0
628
2019
Q3
Sell
-9
Closed -$1K 622
2019
Q2
$1K Hold
9
﹤0.01% 543
2019
Q1
$1K Hold
9
﹤0.01% 544
2018
Q4
$1K Sell
9
-7
-44% -$778 ﹤0.01% 643
2018
Q3
$4K Hold
16
﹤0.01% 566
2018
Q2
$34K Hold
16
0.01% 289
2018
Q1
$40K Hold
16
0.01% 261
2017
Q4
$29K Hold
16
﹤0.01% 305
2017
Q3
$18K Hold
16
﹤0.01% 349
2017
Q2
$12K Hold
16
﹤0.01% 393
2017
Q1
$11K Hold
16
﹤0.01% 408
2016
Q4
$11K Hold
16
﹤0.01% 404
2016
Q3
$18K Sell
16
-5
-24% -$5.63K ﹤0.01% 337
2016
Q2
$16K Buy
21
+8
+62% +$6.1K ﹤0.01% 361
2016
Q1
$9K Hold
13
﹤0.01% 423
2015
Q4
$14K Hold
13
﹤0.01% 375
2015
Q3
$14K Hold
13
﹤0.01% 371
2015
Q2
$28K Hold
13
0.01% 291
2015
Q1
$12K Hold
13
﹤0.01% 404
2014
Q4
$14K Buy
13
+8
+160% +$8.62K ﹤0.01% 391
2014
Q3
$5K Hold
5
﹤0.01% 494
2014
Q2
$10K Hold
5
﹤0.01% 420
2014
Q1
$11K Hold
5
﹤0.01% 405
2013
Q4
$12K Sell
5
-5
-50% -$12K ﹤0.01% 391
2013
Q3
$27K Buy
10
+5
+100% +$13.5K 0.01% 290
2013
Q2
$46K Buy
+5
New +$46K 0.01% 223